ArticleMolecular medicine reports2020

Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.